3/18
03:09 pm
CHRS
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Coherus BioSciences, Inc. (NASDAQ: CHRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
1/23
03:04 pm
CHRS
Rating for CHRS
Low
Report
Rating for CHRS
1/23
03:04 pm
CHRS
Rating for CHRS
Low
Report
Rating for CHRS